The Precision Oncology Frontier: How the Hematological Malignancies Disease Market Is Advancing Blood Cancer Care
Blood cancers, including leukemia, lymphoma, and myeloma, represent a significant and growing global health challenge. However, the treatment landscape for these malignancies is undergoing a profound transformation, moving from traditional chemotherapy towards more precise, targeted, and immune-based therapies. The Hematological Malignancies Disease Market, valued at USD 29.6 Billion in 2025,...
0 Комментарии 0 Поделились 6 Просмотры 0 предпросмотр